S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)

Cross Country Healthcare (CCRN) Stock Forecast & Price Target

$20.89
+0.61 (+3.01%)
(As of 12/7/2023 ET)
Compare
Today's Range
$19.79
▼
$20.90
50-Day Range
$17.94
▼
$25.55
52-Week Range
$15.65
▼
$33.42
Volume
306,388 shs
Average Volume
536,842 shs
Market Capitalization
$734.30 million
P/E Ratio
7.41
Dividend Yield
N/A
Price Target
$26.71
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Cross Country Healthcare Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 9 Analyst Ratings

Analysts' Consensus Price Target

$26.71
27.88% Upside
High Forecast$40.00
Average Forecast$26.71
Low Forecast$21.00
TypeCurrent Forecast
12/7/22 to 12/7/23		1 Month Ago
11/7/22 to 11/7/23		3 Months Ago
9/8/22 to 9/8/23		1 Year Ago
12/7/21 to 12/7/22
Consensus Rating
Hold
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
Hold
5 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$26.71$28.00$30.00$36.20
Predicted Upside27.88% Upside24.29% Upside21.59% Upside29.78% Upside
Get Cross Country Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CCRN and its competitors with MarketBeat's FREE daily newsletter.


CCRN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CCRN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cross Country Healthcare Stock vs. The Competition

TypeCross Country HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.44
2.68
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside31.73% Upside652.22% Upside2,089.55% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/6/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageMarket Perform
11/30/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageNeutral$22.00+7.79%
11/29/2023Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperform ➝ Outperform$29.00 ➝ $26.00+24.88%
11/3/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetHold ➝ Hold$25.00 ➝ $22.00+10.50%
11/3/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Hold$32.00 ➝ $21.00+5.47%
8/8/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetNeutral ➝ Neutral$27.00 ➝ $26.00+17.17%
6/26/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating		T. Romeo
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageOutperform
3/9/2023Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$30.00+18.30%
2/23/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy$45.00 ➝ $40.00+61.36%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:07 PM ET.












CCRN Price Target - Frequently Asked Questions

What is Cross Country Healthcare's consensus rating and price target?

According to the issued ratings of 9 analysts in the last year, the consensus rating for Cross Country Healthcare stock is Hold based on the current 5 hold ratings and 4 buy ratings for CCRN. The average twelve-month price prediction for Cross Country Healthcare is $26.71 with a high price target of $40.00 and a low price target of $21.00. Learn more on CCRN's analyst rating history.

Do Wall Street analysts like Cross Country Healthcare more than its competitors?

Analysts like Cross Country Healthcare less than other Medical companies. The consensus rating for Cross Country Healthcare is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how CCRN compares to other companies.

Does Cross Country Healthcare's stock price have much upside?

According to analysts, Cross Country Healthcare's stock has a predicted upside of 21.91% based on their 12-month stock forecasts.

What analysts cover Cross Country Healthcare?

Cross Country Healthcare has been rated by Barrington Research, Jefferies Financial Group, JMP Securities, Truist Financial, and UBS Group in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:CCRN) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -